NRBO: NeuroBo Pharmaceuticals, Inc. Stock

by  •  • Comments Off on NRBO: NeuroBo Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 22.37
Enterprise Value ($M) 6.38
Book Value ($M) 10.08
Book Value / Share 2.05
Price / Book 2.22
NCAV ($M) 9.82
NCAV / Share 2.00
Price / NCAV 2.28

Profitability (mra)
Return on Invested Capital (ROIC) -1.62
Return on Assets (ROA) -0.53
Return on Equity (ROE) -0.81

Liquidity (mrq)
Quick Ratio 2.46
Current Ratio 2.46

Balance Sheet (mrq) ($M)
Current Assets 16.76
Assets 17.02
Liabilities 6.94
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -15.89
Net Income -12.47
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -10.80
Cash from Investing -0.05
Cash from Financing -0.08

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-17 4,402 10,624 41.43
2024-05-16 11,552 55,637 20.76
2024-05-15 3,044 1,133 268.67
2024-05-14 2,436 999 243.84
2024-05-13 391 5,566 7.02

(click for more detail)

Similar Companies
NEXI – NexImmune, Inc. NKTR – Nektar Therapeutics
NLSP – NLS Pharmaceutics Ltd. NRSN – NeuroSense Therapeutics Ltd.
NRXP – NRx Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io